Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
November 02 2021 - 12:42PM
Business Wire
Quidel Corporation announced today that it will serve as sponsor
for the upcoming Distinguished Speaker Series being conducted by
the Bay Area Lyme Foundation. Quidel is a California-based
diagnostic health care manufacturer known for successfully
developing rapid diagnostic health solutions, including the
industry-leading Sofia® 2 Lyme FIA test for Lyme disease.
The Distinguished Speaker Series are free community events that
provide new information on various Lyme-related topics. Speakers
typically feature an esteemed scientific researcher paired with a
Lyme survivor sharing their inspirational story in an
open-discussion format. The events are designed to create a more
informed, connected and inspired public, which, in turn, will lead
to stronger families, schools, businesses and communities.
“We share the Bay Area Lyme Foundation’s mission to make Lyme
disease easy to diagnose and simple to cure,” said Judi Tilghman,
Ph.D., vice president of technology assessment at Quidel. “Over the
years the Foundation has collaborated with world-class scientists
and institutions to accelerate medical breakthroughs for Lyme
disease and to build a more informed and engaged public. We are
honored to sponsor this important speakers series in support of
those efforts.”
On Nov. 3, the series will feature a researcher, physician and
Lyme patient advocate who will discuss how the immune system “can
protect or attack” when it comes to Lyme disease. The discussion
will focus on the importance of using a broad and comprehensive
diagnostic and treatment approach to Lyme disease. Speakers include
Liz Horn, Ph.D., MBI, principal investigator, Lyme Disease Biobank,
and principal, LHC Biosolutions; Victoria Blaho, Ph.D., assistant
professor, Sanford Burnham Prebys, Immunity and Pathogenesis
Program; and David N. Haney, Ph.D., researcher and family
caregiver.
The Nov. 3 event will be held from 4-7 p.m. in the Sanford
Burnham Prebys Medical Discovery Institute in San Diego.
Reservations are required and can be made at
SpeakerSeries@bayarealyme.org or by calling 650-530-2684. Full
vaccination is required for this venue.
Lyme disease is on the rise to record numbers throughout the
country and has the potential to affect as many as 476,000 citizens
before the year is out. Leading the way in Lyme disease testing is
the innovative Sofia® 2 Lyme FIA by Quidel. This revolutionary test
provides the patient and physician with indicative results within
15 minutes, as opposed to days, which has historically been the
norm (and during which time organisms can spread and become
systemic). It can be performed in the privacy of a doctor’s office,
local clinic or even by a nurse at a children’s summer camp; and it
is the only test that can get results from a simple finger prick of
blood.
About Quidel Corporation
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of
diagnostic solutions at the point of care, delivering a continuum
of rapid testing technologies that further improve the quality of
health care throughout the globe. An innovator for over 40 years in
the medical device industry, Quidel pioneered the first
point-of-care test for influenza in 1999 and was the first to
market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted
brand names, Sofia®, Solana®, Lyra®, Triage® and QuickVue®,
Quidel’s comprehensive product portfolio includes tests for a wide
range of infectious diseases, cardiac and autoimmune biomarkers, as
well as a host of products to detect COVID-19. Quidel’s mission is
to provide patients with immediate and frequent access to highly
accurate, affordable testing for the good of our families, our
communities and the world. For more information about Quidel, visit
quidel.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211102006052/en/
Jim Yeager 818-264-6812 (mobile) jim@breakwhitelight.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From May 2024 to Jun 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jun 2023 to Jun 2024